Thank you and good morning everyone. Today we present the results for the first quarter of 2025. Before diving into the development of the quarter. So just let me zoom out and make some comments on Attendo's status and strategy going forward.
Slide two please. As a private company, our mandate to do business and keep growing is closely linked to our ability to deliver more appreciated and specialized care with higher stakeholder satisfaction, at a lower cost to society than the public sector. Last year, we completed the acquisition and integration of Team Olivia in Sweden and strengthened operational efficiency in Finland. Hence, we entered 2025 with more diversified operations. From an operational point of view, we have made strong progress in terms of stakeholder satisfaction among customers, relatives, employees, and payers. Last year, according to national satisfaction surveys, we achieved higher satisfaction scores among care customers in both markets while delivering care at a significantly lower cost than public providers.
Hence, making room for increased availability of care services. This goes hand in hand with our long-term vision to deliver better care to more people.
Next slide please.
In the first quarter, we grew the top line by around 8%, mainly driven by the acquisition of Team Olivia and more solid bets.
Underlying adjusted EBITDA improved by 7% to 41 million, or 44% to 234 million. An effect of both underlying operational improvements, increased occupancy in nursing homes, and the Team Olivia acquisition in Finland.
In Scandinavia, we delivered expected earnings growth related to the integration of Team Olivia and improvements in our own nursing home operations, mainly from an inflow of new customers. Having said that, we also faced some negative headwinds from home care and a slightly higher cost base due to new openings in recent quarters. This adjusted EBITDA per share continued to improve to 4.63 SEK, an improvement by 46% compared to the first quarter last year. Our strong EPS growth is mainly linked to higher earnings, but also an effect of our share buyback program, reducing the number of outstanding shares. All in all, we're well on track towards our adjusted EPS goal of a minimum of 5.50 per share in 2026. Notes and comments on the progress of our sustainability work and non-financial KPIs.
Over the past few years, we have gradually been implementing new evidence-based methods to measure the quality of life of individual nursing home residents. While we've been piloting these methods since 2021, we've now implemented them broadly in all of our nursing homes.
In Sweden, we've introduced a method called ASCOT - Adult Social Care Outcomes Toolkit, while we use a method called RAI - Residence Assessment Instrument in Finland.
The purpose is to measure and improve the health and well-being of our nursing home residents. The results of the ASCOT - Adult Social Care Outcomes Toolkit and RAI - Residence Assessment Instrument assessments help our staff to better understand what to focus on, to impact quality of life for each individual resident. It also provides data to understand if the resident experiences a positive impact from the care, food, and services we provide. The results indicate that this approach to improving quality of life is positively impacting nursing home residents. While it's still too early to draw more detailed conclusions from the measurements, we will, as we get more data, be able to compare development over time.
This will also help us to build more knowledge about what actions have the most impact on our residents' health and well-being. To further develop our care operations for the future. Next slide please. So let's turn to occupancy development in Scandinavia.
We saw a solid inflow of new customers early in the quarter. Hence, occupancy remained almost flat in Scandinavia at 87%, despite the opening of a new 60-bed nursing home in Stockholm during the quarter. Finland showed a more distinct improvement in the quarter, bouncing back from the seasonal effect that brought occupancy down over the Christmas holidays.
During the quarter, we also made two acquisitions with a total of 200 beds at 90% occupancy, which, in combination with the closure of a few low occupancy units, also impacted the occupancy level positively.
This graph shows rolling 12-month sales growth and adjusted EBITDA margin. Sales continued to improve during the quarter, mainly driven by the acquisition of Team Olivia in Sweden, and more solid bets. Sales in Finland remained strong despite flat prices compared to last year, as a result of the lower staffing requirements valid from January 1st.
If we look at the group margin, we continue to improve as more solid bets and higher staffing efficiency in Finland drive earnings recovery in Scandinavia.
We improved margins due to enhanced operational efficiency in all nursing homes and the Team Olivia acquisitions, slightly offset by weak development in the home care segment. As part of our strategy, we have terminated a few selected home care contracts with unsustainable business terms during the quarter. So let's take a look at the financials for the quarter.
And please go ahead Mikael. Next slide please. Thank you, Martin, and good morning, everyone. Net sales in the quarter increased to 4.7 billion, up 8% compared to the same quarter last year. The organic growth for the quarter was 2%.
Organic growth was flat in Attendo Scandinavia, where we continue to see organic growth primarily in owned nursing homes. However, growth was also impacted by outsourcing contracts that ended last year, excluding acquisitions. Scandinavia grew by 19%, while Attendo Finland showed different results. The organic growth was 2%, primarily driven by the increase in net new customers, with several of our key segments showing positive growth. Currency had no material effect in the quarter.
However, we do expect currency effects in Q2. Since last year, the euro to SEK was at a higher rate than it is currently trading. Next slide please. The reported result improved to 381 million. And correspondingly, the lease-adjusted EBITDA increased from 161 million to 234 million, up 45% versus the same period last year. This adjusted EBITDA in Scandinavia improved by 26 million year over year, while Finland is still being adjusted. EBITDA improved by 52 million year over year. Currency had no material effect on this adjusted EBITDA. Next slide please. Growth rate in Finland is reported at 1% and 2% in local currency. As earlier mentioned, adjusting for Liberty and the exited rehab business in December last year, the underlying organic growth was approximately 4%. This adjusted EBITDA was 189 million, an improvement of 52 million compared to last year. The Finnish Parliament announcement of changed staffing requirements for care of older people, from 0.65 to 0.60 care staff per resident, took effect from 1st of January 25, and the team delivered an implementation better than the base plan. The quarter improved as already seen in the last quarter from better staffing and manning. Occupancy rate improved when adjusting for seasonality with more sold beds and from exiting a few low or no occupancy units. In the quarter, we also opened a new nursing home and acquired two quality nursing home businesses, which added an additional 200 placements.
Next slide please. In Scandinavia, the organic growth was flat.
We observed underlying growth in our own nursing homes. However, growth was offset by concluding outsourcing contracts. Acquisitions had a considerable effect on sales and, in total, Scandinavia grew by 19%. This adjusted EBITDA increased by SEK 26 million to SEK 68 million.
The improvement was primarily driven by the Team Olivia acquisition and improved results in nursing homes. In the quarter, we opened a new nursing home in Stockholm and closed down one unit, which together had a -10 million SEK impact versus Q1 last year. Next quarter will also be impacted by start-up costs as we're opening a new home in Denmark, and we carry ramp-up costs from the March opening. In addition, weak home care impacted the results negatively in the quarter. Finally, as part of our strategy, we terminated a few selective home care contracts where sustainable conditions no longer exist in Q2. We expect exits to impact our results by 10 to 15 million in one-time exit costs.
Next slide please. If you look at our cash flow, our cash flow improved to 752 million on a rolling 12-month basis, where Q1 free cash flow was 40 million versus 20 million last year. CapEx was higher and, as previously communicated, is continuing to normalize at more historical levels compared to last year's low.
During the quarter, we also executed a robust share repurchase program, buying back a total of 162 million worth of shares.
The cash flow was further impacted by recent acquisitions, which totaled 125 million SEK in the quarter.
Next slide please. Over the course of the last 12 months, in line with our financial plan for '24 to '26, we initiated a more active capital allocation.
As a result, we have utilized more than 80% of our free cash flow for dividends and share buybacks. In addition, we made a transformative acquisition with Team Olivia in April, which was followed by two quality bolt-on acquisitions in Finland this quarter. Next slide please. Let's have a look at our key financial metrics. And I'm happy to share that our key metrics continue to move in the right direction. If we start at the top left, the adjusted earnings per share improved by $0.05 to $0.06 per share, almost doubling the EPS versus last year. Improvements are primarily due to higher adjusted EBITDA, but also lower financial costs and our share buybacks, which continue to support the improvement. If we turn to the top right figure and our adjusted margin in percent, adjusted for non-recurring items, we continue to improve our adjusted margin in Q1. The rolling 12-month margin was 5.7%, up from 5.4% last quarter and up 1.2 percentage points compared to Q1 last year. If we direct our attention to the figure at the bottom left, we maintain our adjusted net debt to EBITDA ratio versus last quarter, which is in line with our target range of 1.5 to 2.5 ratio.
And finally, when we look at the figure on the bottom right, net interest expenses in the quarter were 31 million.
The increase in Q2 and Q3 is explained mainly by higher financing costs due to the recent acquisitions, while in Q4 and Q1, we see the effect of improved market interest rates. With that, I hand over to you, Martin.
Thank you. Miguel. Next slide please. So before we move on to Q&A, let me briefly summarize. So we started this year with the same strong trajectory as we ended last year.
Improvements in financial performance stem mainly from our Finnish business, where quick adaptation to new staffing requirements and operational improvements have led to continued solid earnings growth. We also made two bolt-on acquisitions during the quarter and continued to optimize our footprint by closing some non-performing units.
We maintain a positive outlook for the year ahead, as lower staffing requirements also give regions financial relief that can transform into higher demand for nursing home placements in Sweden.
The Team Olivia acquisition has strengthened our operations and contributed positively to our financial development. We expect to further improve operational efficiency post-integration period and build a stronger platform for growth within both businesses, both disabled care and IOF.
I'm also happy to see more sold beds in nursing homes, and that our newly opened nursing homes, added in late 2020 and early 2025, are filling up quickly. All in all, we're well on track towards our adjusted EPS target of at least $5.50 per share in 2026.
So that concludes our presentation and let's turn to the Q&A session.
So operator, please go ahead.